Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
© Mattingly et al.; licensee BioMed Central Ltd. 2013
Received: 7 December 2011
Accepted: 11 January 2013
Published: 29 January 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting firstname.lastname@example.org.
|7 Dec 2011||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|23 Dec 2011||Author responded||Author comments - Greg Mattingly|
|Resubmission - Version 3|
|23 Dec 2011||Submitted||Manuscript version 3|
|29 May 2012||Reviewed||Reviewer Report - James McGough|
|1 Jun 2012||Reviewed||Reviewer Report - Jadwiga Najib|
|6 Nov 2012||Author responded||Author comments - Greg Mattingly|
|Resubmission - Version 4|
|6 Nov 2012||Submitted||Manuscript version 4|
|10 Nov 2012||Reviewed||Reviewer Report - James McGough|
|15 Nov 2012||Reviewed||Reviewer Report - Jadwiga Najib|
|26 Nov 2012||Author responded||Author comments - Greg Mattingly|
|Resubmission - Version 5|
|26 Nov 2012||Submitted||Manuscript version 5|
|Resubmission - Version 6|
|Submitted||Manuscript version 6|
|4 Jan 2013||Reviewed||Reviewer Report - James McGough|
|Resubmission - Version 7|
|Submitted||Manuscript version 7|
|11 Jan 2013||Editorially accepted|
|29 Jan 2013||Article published||10.1186/1471-244X-13-39|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting email@example.com. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.